Brief: Roche To Present Late-Stage Lung And Breast Cancer Data At ESMO 2026
Mon 06:10
BRIEF-Roche To Present Late-Stage Lung And Breast Cancer Data At ESMO 2026 Oct 19 (Reuters) - ROCHE HOLDING AG ROPC.S:
ROCHE TO PRESENT PIVOTAL DATA AT ESMO 2026, SHOWCASING ADVANCES ACROSS ITS LUNG AND BREAST CANCER LATE-STAGE PORTFOLIO
Source text: ID:nGNE5lVz1q
Further company coverage: ROPC.S
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587785269;))
Recent news on Roche Holding AG
See all newsNovartis presents weaker-than-expected relapse data for multiple sclerosis drug remibrutinib
Brief: Roche Says Sefaxersen Achieved Statistically Significant 43.1% Reduction In Proteinuria In Interim Phase III Data
Brief: Zymeworks Signs Exclusive Global Licensing Deal With Roche For Cancer Drug ZW209
Zymeworks licenses experimental lung cancer drug to Roche in up to $813 million deal
DB ups Roche to 'buy' on positive oncology survey